Xolair (omalizumab) for uncontrolled asthma
|
8
|
Published
|
October 2005
|
April 2003
|
November 2007
|
November 2006
|
Remicade (infliximab) for psoriasis
|
8
|
Published
|
September 2005
|
April 2003
|
January 2008
|
March 2007
|
Natrecor (nesiritide), Heart failure (acute decompensated)
|
9
|
Ongoing
|
n/a
|
October 2003
|
n/a
|
October 2003
|
Erbitux (cetuximab), Head and neck cancer
|
10
|
Published
|
n/a
|
June 2004
|
June 2008
|
June 2006
|
Iressa (gefitinib), lung cancer (non-small cell)
|
10
|
Ongoing
|
n/a
|
June 2004
|
n/a
|
January 2009
|
Tysabri (natalizumab) for the treatment of multiple sclerosis
|
10
|
Published
|
June 2006
|
June 2004
|
August 2007
|
September 2006
|
Alimta (pemetrexed) for mesothelioma
|
10
|
Published
|
September 2004
|
June 2004
|
January 2008
|
April 2005
|
Erbitux (cetuximab) for head and neck cancer
|
10
|
Published
|
March 2006
|
June 2004
|
June 2008
|
June 2006
|
Campto (irinotecan), colon cancer (adjuvant)
|
10
|
Ongoing
|
n/a
|
June 2004
|
n/a
|
n/a
|
Mabthera (rituximab) for untreated stage III or IV follicular lymphoma
|
11
|
Published
|
August 2004
|
April 2005
|
September 2006
|
April 2007
|
Taxol (paclitaxel) for early node-positive breast cancer
|
11
|
Published
|
March 2005
|
April 2005
|
September 2006
|
November 2005
|
Taxotere (docetaxel) for early node-positive breast cancer
|
11
|
Published
|
March 2006
|
April 2005
|
September 2006
|
November 2005
|
Gemzar (gemcitabine) for metastatic breast cancer
|
11
|
Published
|
September 2004
|
April 2005
|
January 2007
|
February 2006
|
Fludara (fludarabine) for chronic lymphocytic leukaemia
|
11
|
Published
|
February 2003
|
April 2005
|
February 2007
|
February 2006
|
Alimta (pemetrexed) for the treatment of non-small cell lung cancer
|
11
|
Published
|
n/a
|
April 2005
|
August 2007
|
April 2006
|
Tarceva (erlotinib), lung cancer (non-small cell)
|
11
|
Ongoing
|
September 2005
|
April 2005
|
n/a
|
March 2009
|
Idraparinux sodium, atrial fibrillation
|
12
|
Ongoing
|
n/a
|
July 2006
|
n/a
|
July 2006
|
Arava (leflunomide), psoriatic arthritis (moderate to severe)
|
12
|
Ongoing
|
June 2004
|
July 2006
|
n/a
|
July 2006
|
Idraparinux sodium, venous thromboembolism (recurrent)
|
12
|
Ongoing
|
n/a
|
July 2006
|
n/a
|
July 2006
|
Herceptin (trastuzumab) for early-stage HER2-positive breast cancer
|
12
|
Published
|
May 2006
|
July 2005
|
August 2006
|
December 2005
|
6 Oct 2008 : Column 449W
6 Oct 2008 : Column 450W
Alteplase (Actilyse) for the treatment of acute ischaemic stroke
|
12
|
Published
|
June 2002
|
July 2006
|
June 2007
|
September 2006
|
Champix (varenicline) for smoking cessation
|
12
|
Published
|
September 2006
|
July 2006
|
July 2007
|
November 2006
|
Humira (adalimumab) for the treatment of psoriatic arthritis
|
12
|
Published
|
August 2005
|
July 2005
|
August 2007
|
September 2006
|
MabThera (rituximab) for the treatment of rheumatoid arthritis
|
12
|
Published
|
July 2006
|
July 2005
|
August 2007
|
September 2006
|
Velcade (bortezomib) for multiple myeloma
|
12
|
Published
|
April 2004
|
July 2005
|
October 2007
|
December 2005
|
Orencia (abatacept) for rheumatoid arthritis
|
12
|
Published
|
May 2007
|
July 2006
|
April 2008
|
October 2006
|
Tyverb (lapatinib), breast cancer (advanced or metastatic)
|
13
|
Ongoing
|
June 2008
|
December 2006
|
n/a
|
February 2007
|
Cimzia (certolizumab), rheumatoid arthritis
|
13
|
Ongoing
|
n/a
|
December 2006
|
n/a
|
December 2006
|
Remicade (infliximab), ulcerative colitis (acute exacerbations)
|
13
|
Ongoing
|
February 2006
|
December 2006
|
n/a
|
March 2007
|
Remicade (infliximab) for ulcerative colitis
|
13
|
Published
|
February 2006
|
December 2006
|
April 2008
|
March 2007
|
Acomplia (rimonabant) for obesity
|
13
|
Published
|
June 2006
|
December 2006
|
June 2008
|
June 2007
|
Baraclude (entecavir), Hepatitis B
|
14
|
Ongoing
|
June 2006
|
June 2007
|
August 2008
|
September 2007
|
Sebivo (telbivudine), Hepatitis B
|
14
|
Ongoing
|
April 2007
|
June 2007
|
August 2008
|
September 2007
|
Adenuric (febuxostat), hyperuricaemia
|
14
|
Ongoing
|
April 2008
|
June 2007
|
n/a
|
August 2007
|
Humira (adalimumab) for the chronic psoriasis
|
14
|
Published
|
December 2007
|
June 2007
|
June 2008
|
July 2007
|
Ixabepilone, breast cancer (locally advanced or metastatic)
|
15
|
Ongoing
|
n/a
|
December 2007
|
n/a
|
July 2008
|
Erbitux (cetuximab), colorectal cancer (first line)
|
15
|
Ongoing
|
July 2008
|
December 2007
|
n/a
|
January 2008
|
Erbitux (cetuximab), lung cancer (non-small cell)
|
15
|
Ongoing
|
n/a
|
December 2007
|
n/a
|
October 2008
|
Revlimid (lenalidomide), multiple myeloma
|
15
|
Ongoing
|
June 2007
|
December 2007
|
n/a
|
April 2008
|
Xeloda (capectitabine), pancreatic cancer
|
15
|
Ongoing
|
n/a
|
December 2007
|
n/a
|
June 2009
|
Pradaxa (dabigatran), venous thromboembolism
|
15
|
Ongoing
|
March 2008
|
December 2007
|
n/a
|
January 2008
|
Erbitux (cetuximab), head and neck cancer (squamous cell carcinoma)
|
16
|
Ongoing
|
March 2006
|
March 2008
|
n/a
|
March 2008
|
Effient (prasugrel), acute coronary artery syndrome
|
17
|
Ongoing
|
n/a
|
June 2008
|
n/a
|
November 2008
|
Viread (tenofovir disoproxil fumarate), Hepatitis B
|
17
|
Ongoing
|
April 2008
|
June 2008
|
n/a
|
August 2008
|
Nexavar (sorafenib), hepatocellular carcinoma (advanced and metastatic)
|
17
|
Ongoing
|
October 2007
|
June 2008
|
n/a
|
August 2008
|
Orencia (abatacept), juvenile idiopathic arthritis
|
17
|
Ongoing
|
May 2007
|
June 2008
|
n/a
|
January 2009
|
Humira (adalimumab), juvenile idiopathic arthritis
|
17
|
Ongoing
|
n/a
|
June 2008
|
n/a
|
September 2008
|
Sprycel (dasatinib), leukaemia (acute lymphoblastic)
|
17
|
Ongoing
|
November 2006
|
June 2008
|
n/a
|
July 2008
|
6 Oct 2008 : Column 451W
6 Oct 2008 : Column 452W
Temodal (temoazolomide), melanoma (advanced and metastatic
|
17
|
Ongoing
|
June 2005
|
June 2008
|
n/a
|
March 2009
|
Mifamurtide, Osteosarcoma
|
17
|
Ongoing
|
n/a
|
June 2008
|
n/a
|
August 2008
|
Romiplostim, thrombocytompenic pupura
|
17
|
Ongoing
|
n/a
|
June 2008
|
n/a
|
August 2008
|
Promacta (eltrombopag), thrombocytopenic purpura
|
17
|
Ongoing
|
n/a
|
June 2008
|
n/a
|
March 2009
|
Xarelto (rivaroxaban), venous thromboembolism
|
17
|
Ongoing
|
n/a
|
June 2008
|
n/a
|
August 2008
|
Azacitidine, acute myelomonocytic leukaemia and acute myeloid leukaemia
|
18
|
Ongoing
|
n/a
|
July 2008
|
n/a
|
January 2009
|
Xeloda (capecitabine), advanced gastric cancer
|
18
|
Ongoing
|
January 2008
|
July 2008
|
n/a
|
December 2008
|
Methylnaltrexone, opioid-induced constipation in patients receiving palliative care
|
18
|
Ongoing
|
n/a
|
July 2008
|
n/a
|
February 2009
|
Datiros (alitretinoin), severe chronic hand eczema
|
18
|
Ongoing
|
n/a
|
July 2008
|
n/a
|
October 2008
|
Alimta (pemetrexed), locally advanced or metastatic non-small cell lung cancer
|
18
|
Ongoing
|
April 2008
|
July 2008
|
n/a
|
June 2009
|
Mabthera (rituximab), relapsed treatment of chronic lymphocytic leukaemia
|
18
|
Ongoing
|
n/a
|
July 2008
|
n/a
|
September 2009
|
Mabthera (rituximab), chronic lymphocytic leukaemia.
|
18
|
Ongoing
|
n/a
|
July 2008
|
n/a
|
September 2008
|
Sutent (sunitinib), gastrointestinal stromal tumours
|
18
|
Ongoing
|
July 2006
|
July 2008
|
n/a
|
August 2008
|
Actemra (tocilizumab), rheumatoid arthritis
|
18
|
Ongoing
|
n/a
|
July 2008
|
n/a
|
November 2008
|
Hycamtin (topotecan), carcinoma of the cervix
|
18
|
Ongoing
|
n/a
|
July 2008
|
n/a
|
December 2008
|
Yondelis (trabectedin), advanced metastatic soft tissue sarcoma
|
18
|
Ongoing
|
September 2007
|
July 2008
|
n/a
|
September 2008
|
Ustekinumab, moderate to severe psoriasis
|
18
|
Ongoing
|
n/a
|
July 2008
|
n/a
|
November 2008
|